{
    "title": "103_s340",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Animal Medicinal Drug Use \nClarification Act of 1994''.\n\nSEC. 2. UNAPPROVED USES.\n\n    (a) General Rule.--Section 512(a) of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 360b(a)) is amended by adding the following new \nparagraphs at the end:\n    ``(4)(A) Except as provided in subparagraph (B), if an approval of \nan application filed under subsection (b) is in effect with respect to \na particular use or intended use of a new animal drug, the drug shall \nnot be deemed unsafe for the purposes of paragraph (1) and shall be \nexempt from the requirements of section 502(f) with respect to a \ndifferent use or intended use of the drug, other than a use in or on \nanimal feed, if such use or intended use--\n        ``(i) is by or on the lawful written or oral order of a \n    licensed veterinarian within the context of a veterinarian-client-\n    patient relationship, as defined by the Secretary; and\n        ``(ii) is in compliance with regulations promulgated by the \n    Secretary that establish the conditions for such different use or \n    intended use.\nThe regulations promulgated by the Secretary under clause (ii) may \nprohibit particular uses of an animal drug and shall not permit such \ndifferent use of an animal drug if the labeling of another animal drug \nthat contains the same active ingredient and which is in the same \ndosage form and concentration provides for such different use.\n    ``(B) If the Secretary finds that there is a reasonable probability \nthat a use of an animal drug authorized under subparagraph (A) may \npresent a risk to the public health, the Secretary may--\n        ``(i) establish a safe level for a residue of an animal drug \n    when it is used for such different use authorized by subparagraph \n    (A); and\n        ``(ii) require the development of a practical, analytical \n    method for the detection of residues of such drug above the safe \n    level established under clause (i).\nThe use of an animal drug that results in residues exceeding a safe \nlevel established under clause (i) shall be considered an unsafe use of \nsuch drug under paragraph (1). Safe levels may be established under \nclause (i) either by regulation or order.\n    ``(C) The Secretary may by general regulation provide access to the \nrecords of veterinarians to ascertain any use or intended use \nauthorized under subparagraph (A) that the Secretary has determined may \npresent a risk to the public health.\n    ``(D) If the Secretary finds, after affording an opportunity for \npublic comment, that a use of an animal drug authorized under \nsubparagraph (A) presents a risk to the public health or that an \nanalytical method required under subparagraph (B) has not been \ndeveloped and submitted to the Secretary, the Secretary may, by order, \nprohibit any such use.\n    ``(5) If the approval of an application filed under section 505 is \nin effect, the drug under such application shall not be deemed unsafe \nfor purposes of paragraph (1) and shall be exempt from the requirements \nof section 502(f) with respect to a use or intended use of the drug in \nanimals if such use or intended use--\n        ``(A) is by or on the lawful written or oral order of a \n    licensed veterinarian within the context of a veterinarian-client-\n    patient relationship, as defined by the Secretary; and\n        ``(B) is in compliance with regulations promulgated by the \n    Secretary that establish the conditions for the use or intended use \n    of the drug in animals.''.\n    (b) Other Amendments.--\n        (1) Section 301.--Section 301 of the Federal Food, Drug, and \n    Cosmetic Act (21 U.S.C. 331) is amended--\n            (A) in paragraph (e), by striking ``507(d) or (g),'' and \n        inserting ``507(d) or (g), 512(a)(4)(C),''; and\n            (B) by adding at the end the following:\n    ``(u) The failure to comply with any requirements of the provisions \nof, or any regulations or orders of the Secretary, under section \n512(a)(4)(A), 512(a)(4)(D), or 512(a)(5).''.\n        (2) Section 512(e).--Section 512(e)(1)(A) of the Federal Food, \n    Drug and Cosmetic Act (21 U.S.C. 360b(e)(1)(A)) is amended by \n    inserting before the semicolon the following: ``or the condition of \n    use authorized under subsection (a)(4)(A)''.\n        (3) Section 512(l).--Section 512(l)(1) of the Federal Food, \n    Drug, and Cosmetic Act (21 U.S.C. 360b(l)(1)) is amended by \n    striking ``relating to experience'' and inserting ``relating to \n    experience, including experience with uses authorized under \n    subsection (a)(4)(A),''.\n    (c) Regulations.--Not later than 2 years after the date of the \nenactment of this Act, the Secretary of Health and Human Services shall \npromulgate regulations to implement paragraphs (4)(A) and (5) of \nsection 512(a) of the Federal Food, Drug, and Cosmetic Act (as amended \nby subsection (a)).\n    (d) Effective Date.--The amendments made by this section shall take \neffect upon the adoption of the final regulations under subsection (c).\n\nSEC. 3. MAPLE SYRUP.\n\n    (a) Preemption.--Section 403A(a) of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 343-1(a)) is amended--\n        (1) in paragraph (1), by inserting at the end the following: \n    ``except that this paragraph does not apply to a standard of \n    identity of a State or political subdivision of a State for maple \n    syrup that is of the type required by sections 401 and 403(g),'';\n        (2) in paragraph (2), by inserting at the end the following: \n    ``except that this paragraph does not apply to a requirement of a \n    State or political subdivision of a State that is of the type \n    required by section 403(c) and that is applicable to maple \n    syrup,''; and\n        (3) in paragraph (3) by inserting at the end the following: \n    ``except that this paragraph does not apply to a requirement of a \n    State or political subdivision of a State that is of the type \n    required by section 403(h)(1) and that is applicable to maple \n    syrup,''.\n    (b) Procedure.--Section 701(e)(1) (21 U.S.C. 371(e)(1)) is amended \nby striking ``or maple syrup (regulated under section 168.140 of title \n21, Code of Federal Regulations).''.\n\n\n\n\n\n\n\n                               Speaker of the House of Representatives.\n\n\n\n\n\n\n\n                            Vice President of the United States and    \n                                               President of the Senate."
}